Canaccord Genuity Maintains Buy on Compass Pathways, Raises Price Target to $20

Benzinga Newsdesk www.benzinga.com Positive 78.9%

Neg 0% Neu 0% Pos 78.9%

Canaccord Genuity analyst Sumant Kulkarni maintains Compass Pathways (NASDAQ:CMPS) with a Buy and raises the price target from $18 to $20.